Edmund Potere described in his deposition that Cutter would no longer release Koate from prison plasma. Read more about Edmund Potere described in his deposition that Cutter would no longer release Koate from prison plasma.
Memo from Robert Barden to Dr John Hink recommended accepting an invitation from the warden of Arizona State Prison to establish a plasmapheresis centre there as it represented a "great opportunity for us to produce some low cost plasma." Read more about Memo from Robert Barden to Dr John Hink recommended accepting an invitation from the warden of Arizona State Prison to establish a plasmapheresis centre there as it represented a "great opportunity for us to produce some low cost plasma."
Hyland's policy as of the end of October 1983 was to discontinue the use of prison plasma for the manufacture of coagulation factors. However, "Any intermediate fractions manufactured from plasma pooled [that] week, or in previous weeks, would be processed to final product." Read more about Hyland's policy as of the end of October 1983 was to discontinue the use of prison plasma for the manufacture of coagulation factors. However, "Any intermediate fractions manufactured from plasma pooled [that] week, or in previous weeks, would be processed to final product."
Dr Ojala estimated that prison plasma accounted for approximately 2% of the total plasma collected in the US as of mid 1982 and was obtained from no more than six to eight centres. Read more about Dr Ojala estimated that prison plasma accounted for approximately 2% of the total plasma collected in the US as of mid 1982 and was obtained from no more than six to eight centres.
Hyland and Cutter obtained plasma from plasmapheresis centres located in prisons in the US and used that plasma in the production of factor concentrates. Read more about Hyland and Cutter obtained plasma from plasmapheresis centres located in prisons in the US and used that plasma in the production of factor concentrates.
William Hartin stated that dealing with paid donors increases the likelihood of people from the lower socioeconomic bracket becoming donors. Read more about William Hartin stated that dealing with paid donors increases the likelihood of people from the lower socioeconomic bracket becoming donors.
A memo from Robert Spiller to Dr Harry Meyer criticised the Bureau of Biologics practice of giving advance notice before some inspections. Read more about A memo from Robert Spiller to Dr Harry Meyer criticised the Bureau of Biologics practice of giving advance notice before some inspections.
A memo from Stewart Mueller to W Biles detailed Dr Jones's inspections of Plasma Alliance. Read more about A memo from Stewart Mueller to W Biles detailed Dr Jones's inspections of Plasma Alliance.
Travenol Laboratories implemented a Guidance for Whole Blood and Plasma Processing Log. This was described as akin to the quality assurance plans as part of product licence applications provided to UK authorities. Read more about Travenol Laboratories implemented a Guidance for Whole Blood and Plasma Processing Log. This was described as akin to the quality assurance plans as part of product licence applications provided to UK authorities.
Travenol Laboratories implemented a Guidance for Source Plasma (Human) Label. This was described as akin to the quality assurance plans as part of product licence applications provided to UK authorities. Read more about Travenol Laboratories implemented a Guidance for Source Plasma (Human) Label. This was described as akin to the quality assurance plans as part of product licence applications provided to UK authorities.